LATEST ARTICLES

Equities, Investment & Market Trends

Trulieve Files Applications for DEA Registration of State-Licensed Medical Marijuana Businesses

Steven Gothrinet -
Equities, Investment & Market Trends

European Hemp Industry Faces Persistent Regulatory Obstacles Despite Binding EU Legal Precedents

Steven Gothrinet -
Clinical Trials & Medical Research

Review Highlights Investigational Pharmacological Treatments for Gambling Disorder

Gillian Jalimnson -
Access & Prescribing (Australia & Global)

Cann Group Advances Share Quotation on ASX All Ordinaries, Signalling Growth in Medicinal Cannabis Sector

Steven Gothrinet -
Cannabinoid Pharmacology

Medical Cannabis for ADHD: Examining the Limited Clinical Evidence and Patient Perceptions

Gillian Jalimnson -
Clinical Trials & Medical Research

Department of Justice Reconsiders Cannabis Gun Prosecutions Amidst Broader Federal Regulatory Debates

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Federal Healthcare Coverage for Hemp-Derived CBD Products Stymied by Absence of Enforceable Product Standards

Steven Gothrinet -
Australian Cannabis Policy & Law

Pennsylvania Gubernatorial Race Highlights Divergent Stances on Cannabis Legalization

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Curaleaf Completes Full Acquisition of Four 20 Pharma, Solidifying Position in German Medical Cannabis Market

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Maryland Psychedelics Task Force Extended Through 2027 to Develop Therapeutic Access Framework

Steven Gothrinet -
1...434445...316Page 44 of 316

MOST POPULAR

Cannabinoid Pharmacology

Bacteria Killer? Research Suggests Cannabidiol Has Antibiotic Potential

Steven Gothrinet -
Preliminary research out of the University of Queensland's Institute for Molecular Bioscience indicates the cannabinoid cannabidiol is effective in killing bacteria in lab testing...
Read more
Access & Prescribing (Australia & Global)

Another Australian Medical Cannabis Company Lists On The ASX

Steven Gothrinet -
A new medicinal cannabis firm appeared on the Australian Stock Exchange on Friday - Althea (ASX:AGH).Based in Melbourne, Victoria, Althea Group Holdings Limited is...
Read more
Access & Prescribing (Australia & Global)

Australia’s “GreenLight” Medical Cannabis Campaign

Terry Lassitenaz -
A campaign to put pressure on the Australian Government to "greenlight" medicinal cannabis and alleviate the suffering of thousands of Australians kicked off on...
Read more
Access & Prescribing (Australia & Global)

Home Grows For Connecticut Medical Cannabis Patients

Terry Lassitenaz -
Starting this Friday, patients registered with Connecticut's medical cannabis program can start cultivating at home.From October 1, qualified patients aged 18+ are permitted to...
Read more
Load more